1.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000454401, GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
|
|
2.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: SUMS-5010, Cholangiocarcinoma, Surgery, Drainage, NCT00797121
|
|
3.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 20 and over Sponsor: Other Protocol IDs: Steel vs nitinol, NCT00980889
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RaMM-BO 2.0, NCT01041612
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 19 to 70 Sponsor: Other Protocol IDs: SNUBH-GS-HBP2, B-0712-052-006 (local IRB), NCT01111591
|
|
6.
|
Phase: Phase IV Type: Health services research, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SCH-2010-04, NCT01125865
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H10-02829, NCT01514214
|
|
8.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 170/11, NCT01552291
|
|
9.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CDM00047339, E7059, NCT01774019
|
|
10.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000470411, FFCD-9902, SANOFI-FFCD-9902, LILLY-FFCD-9902, FFCD-FNCLCC-SFRO-9902, NCT00304135
|
|
11.
|
Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Active Age: 12 to 70 Sponsor: Other Protocol IDs: ICMR- D.O No.5/8/7/26/99-ECD-1, NCT01438450
|
|
12.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CRE 2012.153, NCT01721174
|
|
13.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: RFA2012, NCT01739465
|
|
14.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 1110011999, NCT01755013
|
|
15.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CRUK-HE3002, EU-20629, EUDRACT-2005-003318-13, ISRCTN72785446, CRUK-BILCAP, CRUK-BIBF1120, NCT00363584
|
|
16.
|
Phase: Phase III Type: Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 06.23.CLI, NCT00455247
|
|
17.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: EN Vs PN, NCT00809081
|
|
18.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 2009-0056, NCT00869635
|
|
19.
|
Phase: Phase III Type: Educational/Counseling/Training, Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 0909005722, R01NR011872, NCT01272024
|
|
20.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000696193, FRE-FNCLCC-ACCORD-18/0803, FRE-FNCLCC-PRODIGE-12, EUDRACT-2008-004560-39, EU-20982, FNCLCC-ACCORD-18/0803, NCT01313377
|
|
21.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-434, NCT01401907
|
|
22.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: MIRA-001, NCT01413386
|
|
23.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-05-070, NCT01470443
|
|
24.
|
Phase: Phase III Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
|
|
25.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NCCCTS-12-605, NCT01589328
|